Implantable cardioverter defibrillator harm?

Europace

Volumn 14, Issue 8, 2012, Pages 1087-1093

  Gasparini, Maurizio ^a   Nisam, Seah ^b  

^a HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

^b Boston Scientific Corporation   (Belgium)

Author keywords

Cardiac resynchronization therapy (CRT); Implantable cardioverter defibrillator (ICD); Quality of life (QOL); Sudden death

Indexed keywords

CARDIAC RESYNCHRONIZATION THERAPY; CARDIAC RESYNCHRONIZATION THERAPY DEVICE; DEFIBRILLATOR; HEART PACING; HUMAN; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; PRIMARY PREVENTION; PRIORITY JOURNAL; PROGNOSIS; QUALITY OF LIFE; REVIEW; SECONDARY PREVENTION; SUPRAVENTRICULAR TACHYCARDIA; SURVIVAL; THORACOTOMY; TREATMENT INDICATION;

CARDIAC PACING, ARTIFICIAL; CARDIAC RESYNCHRONIZATION THERAPY; DEFIBRILLATORS, IMPLANTABLE; HEART FAILURE; HUMANS; PROGNOSIS; QUALITY OF LIFE;

EID: 84864420361     PISSN: 10995129     EISSN: 15322092     Source Type: Journal    
DOI: 10.1093/europace/eus025     Document Type: Review

References (42)

1. Mirowski M, Reid PR, Mower MM, Watkins L, Gott VL, Schauble JF et al. Termination of malignant ventricular arrhythmias with an implanted automatic defibrilla-tor in human beings. N Engl J Med 1980;303:322-4. (Pubitemid 10040022)
2. Nanthakumar K, Epstein AE, Kay GN, Plumb VJ, Lee DS. Prophylactic implantable cardioverter-defibrillator therapy in patients with left ventricular systolic dysfunction: a pooled analysis of 10 primary prevention trials. J Am Coll Cardiol. 2004;44: 2166-72. (Pubitemid 39576036)
3. Desai AS, Fang JC, Maisel WH, Baughman KL. Implantable defibrillators for the prevention of mortality in patients with nonischemic cardiomyopathy: a meta-analysis of randomized controlled trials. JAMA 2004;292:2874-9. (Pubitemid 39628235)
4. Epstein AE, Dimarco JP, Ellenbogen KA, Estes NA III, Freedman RA, Gettes LS et al. American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhyth-mia Devices); American Association for Thoracic Surgery; Society of Thoracic Surgeons. ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices) developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons. J Am Coll Cardiol 2008;51:e1-62. No abstract available. Erratum in: J Am Coll Cardiol 2009; 53(1):147. J Am Coll Cardiol 2009; 53(16):1473.
5. Authors/Task Force Members, Dickstein K, Vardas PE, Auricchio A, Daubert JC, Linde C, McMurray J et al. 2010 Focused Update of ESC guidelines on device therapy in heart failure: an update of the 2008 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure and the 2007 ESC guidelines for cardiac and resynchronization therapy developed with the special contribution of the Heart Failure Association and the European Heart Rhythm Association. Europace 2010;12:1526-36.
6. Tung R, Zimetbaum P, Josephson ME. A crucial appraisal of implantable cardioverter-defibrillator therapy for the prevention of sudden cardiac death. J Am Coll Cardiol 2008;52:1111-21.
7. Poole JE, Johnson GW, Hellkamp AS, Anderson J, Callans DJ, Raitt MH et al. Prognostic importance of defibrillator shocks in patients with heart failure. N Engl J Med 2008;359:1009-1017.
8. Cleland JG, Daubert JC, Erdmann E, Freemantle N, Gras D, Kappenberger L et al. Cardiac Resynchronization-Heart Failure (CARE-HF) Study Investigators. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med 2005;352:1539-49. (Pubitemid 40517094)
9. Wietholt D, Block M, Isbruch F, Böcker D, Borggrefe M, Shenasa M et al. Clinical experience with antitachycardia pacing and improved detection algorithms in a new implantable cardioverter-defibrillator. J Am Coll Cardiol 1993;21:885-94. (Pubitemid 23106151)
10. Grosse-Meininghaus D, Siebels J, Wolpert Ch, Schulte B, Vogt J, Korte T et al. Efficacy of antitachycardia pacing confirmed by stored electrograms. A retrospective analysis of 613 stored electrograms in implantable defibrillators. Z Kardiol 2002;91:396-403. (Pubitemid 34539171)
11. Wathen MS, Sweeney MO, DeGroot PJ, Stark AJ, Koehler JL, Chisner MB et al. PainFREE Investigators. Shock reduction using antitachycardia pacing for spontaneous rapid ventricular tachycardia in patients with coronary artery disease. Circulation 2001;104:796-801. (Pubitemid 32762678)
12. Wathen MS, DeGroot PJ, Sweeney MO, Stark AJ, Otterness MF, Adkisson WO et al. Prospective randomized multicenter trial of empirical antitachycardia pacing versus shocks for spontaneous rapid ventricular tachycardia in patients with implantable cardioverter-defibrillators: Pacing Fast Ventricular Tachycardia Reduces Shock Therapies (PainFREE Rx II) trial results. Circulation 2004;110: 2591-6. (Pubitemid 39453007)
13. Gasparini M, Menozzi C, Proclemer A, Landolina M, Iacopino S, Carboni A et al. A simplified biventricular defibrillator with fixed long detection intervals reduces implantable cardioverter defibrillator (ICD) interventions and heart failure hospi-talizations in patients with non-ischaemic cardiomyopathy implanted for primary prevention: the RELEVANT Role of long dEtection window programming in patients with LEft VentriculAr dysfunction, Non-ischemic eTiology in primary prevention treated with a biventricular ICD study. Eur Heart J 2009;30:2758-67.
14. Gasparini M, Anselme F, Clementy J, Santini M, Mart́inez-Ferrer J, De Santo T et al. ADVANCE CRT-D Investigators. BIVentricular versus right ventricular antitachy-cardia pacing to terminate ventricular tachyarrhythmias in patients receiving cardiac resynchronization therapy: the ADVANCE CRT-D Trial. Am Heart J. 2010;159:1116-23. e2.
15. Wilkoff BL, Williamson BD, Stern RS, Moore SL, Lu F, Lee SW et al. Strategic programming of detection and therapy parameters in implantable cardioverter-defibrillators reduces shocks in primary prevention patients: results from the PREPARE (Primary Prevention Parameters Evaluation) study. Am Coll Cardiol 2008;52:541-50.
16. Spragg D, Berger R. How to avoid inappropriate shocks. Heart Rhythm 2008;5: 762-5.
17. Gilliam R, Day J, Hayes D, Boehmer J, Heidenreich P, Jones P et al. Comparison of tachycardia detection programming and shock Incidence in the ALTITUDE study. J Cardiovasc Electrophysiol 2011;22:1023-29.
18. Mansour F, Khairy P. Programming ICDs in the modern era beyond out-of-the box settings. Pacing Clin Electrophysiol 2011;34:506-20. doi:10.1111/j.1540- 8159.2011.03037.x. Epub 8 February 2011.
19. Bristow MR, Saxon LA, Boehmer J, Krueger S, Kass DA, De Marco T et al. Cardiac-resynchronization therapy with or with an an implantable defibrillator in advanced chronic heart failure. N Engl J Med 2004;350:2140-50.
20. Linde C, Abraham WT, Gold MR, St John Sutton M, Ghio S, Daubert C et al. Randomized trial of cardiac resynchronization in mildly symptomatic heart failure patients and in asymptomatic patients with left ventricular dysfunction and previous heart failure symptoms. J Am Coll Cardiol 2008;52:1834-43.
21. Moss AJ, Hall WJ, Cannom DS, Klein H, Brown MW, Daubert JP et al. Cardiac-resynchronization therapy for the prevention of heart-failure events. N Engl J Med 2009;361:1329-38.
22. Tang AS, Wells GA, Talajic M, Arnold MO, Sheldon R, Connolly S et al., for the Resynchronization-Defibrillation for Ambulatory Heart Failure Trial (RAFT). Cardiac-resynchronization therapy for mild-to-moderate heart failure. N Engl J Med 2010;363:2385-95.
23. Al-Majed NS, McAlister FA, Bakal JA, Ezekowitz JA. Meta-analysis: cardiac resyn-chronization therapy for patients with less symptomatic heart failure. Ann Intern Med. 2011;154:401-12.
24. Lam S, Owen A. Combined resynchronisation and implantable defibrillator therapy in left ventricular dysfunction. Bayesian network meta-analysis of randomized controlled trials. BMJ 2007;335:925-8. (Pubitemid 350076982)
25. Ellenbogen K, Wood M, Klein H. Why should we care about CARE-HF? J Am Coll Cardiol 2005;46:2199-203. (Pubitemid 41785485)
26. Nisam S, Breithardt G. Lessons learned from neutral ICD trials. Europace 2006;8: 393-7. (Pubitemid 43905711)
27. Bigger JT Jr. Prophylactic use of implanted cardiac defibrillators in patients at high risk for ventricular arrhythmias after coronary-artery bypass graft surgery. Coronary Artery Bypass Graft (CABG) Patch Trial Investigators. N Engl J Med 1997;337: 1569-75. (Pubitemid 27509759)
28. Hohnloser SH, Kuck KH, Dorian P, Roberts RS, Hampton JR, Hatala R et al., DINAMIT Investigators. Prophylactic use of an implantable cardioverter- defibrillator after acute myocardial infarction. N Engl J Med 2004;351:2481-8. (Pubitemid 39603155)
29. Salukhe TV, Dimopoulos K, Sutton R, Coats AJ, Piepoli M, Francis DP et al. Life-years gained from defibrillator implantation: markedly nonlinear increase during 3 years of follow-up and its implications. Circulation 2004;109:1848-53. (Pubitemid 38509118)
30. Goldenberg I, Gillespie J, Moss AJ, Hall WJ, Klein H, McNitt S et al. Long-term benefit of primary prevention with an implantable cardioverter- defibrillator: an extended 8-year follow-up study of the Multicenter Automatic Defibrillator Implantation Trial II. Circulation 2010;122:1265-71.
31. Moss AJ, Greenberg H, Case RB, Zareba W, Hall WJ, Brown MW et al. Long-term clinical course of patients after termination of ventricular tachyarrhythmia by an implantable defibrillator. Circulation 2004;110:3760-5. (Pubitemid 40023973)
32. Dichtl W, Wolber T, Paoli U, Brüllmann S, Stühlinger M, Berger T et al. Appropriate therapy but not inappropriate shocks predict survival in implantable cardioverter defibrillator patients. Clin Cardiol 2011;34:433-6.
33. van Rees JB, Borleffs CJ, de Bie MK, Stijnen T, van Erven L, Bax JJ et al. Inappropriate implantable cardioverter-defibrillator shocks: incidence, predictors, and impact on mortality. JACC 2011;57:556-62.
34. Moss AJ. What we have learned from the family of multicenter automatic defib-rillator implantation trials. Circ J 2010;74:1038-41.
35. Schwab JO, Gasparini M, Lunati M, Proclemer A, Kaup B, Santi E et al. Avoid delivering therapies for nonsustained fast ventricular tachyarrhythmia in patients with implantable cardioverter/defibrillator: the ADVANCE III Trial. J Cardiovasc Electro-physiol 2009;20:663-6.
36. Wilkoff BL, Cook JR, Epstein AE, Greene HL, Hallstrom AP, Hsia H et al. Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial. JAMA 2002;288:3115-23. (Pubitemid 36014128)
37. Burke JL, Hallas CN, Clark-Carter D, White D, Connelly D. The psychosocial impact of the implantable cardioverter defibrillator: a meta-analytic review. Br J Health Psychol 2003;8(Part 2):165-78. (Pubitemid 36565916)
38. Luderitz B, Jung W, Deister A, Manz M. Patient acceptance of implantable cardi-overter defibrillator devices: changing attitudes. Am Heart J. 1994;127(Part 2): 1179-84.
39. Sweeney M, Wathen M, Volosin K, Abdalla I, DeGroot P, Otterness M et al. Appropriate and inappropriate ventricular therapies, quality of life, and mortality among primary and secondary prevention implantable cardioverter defibrillator patients: results from de Pacing Fast VT REduces Shock ThErapies (Pain FREE Rx II) Trial. Circulation 2005;III:2898-905. (Pubitemid 40814182)
40. Ware JE Jr, Sherbourne CD. The MOS 36-item Short-Form Health Survey (SF-36). Med Care 1992;30:473-83.
41. Kleemann T, Becker T, Doenges K, Vater M, Senges J, Schneider S et al. Annual rate of transvenous defibrillation lead defects in implantable cardioverter-defibrillators over a period of.10 years. Circulation 2007;115:2474-80. Epub 30 April 2007. (Pubitemid 46763220)
42. The Cardiac Arrhythmia Suppression Trial (CAST) Investigators. Effect of encai-nide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction. N Engl J Med 1989;321:406-12.